首页 | 本学科首页   官方微博 | 高级检索  
     

葡萄膜炎并发白内障术中前房注射长效糖皮质激素的疗效
引用本文:李锐,袁慧敏,刘钊臣,李勇. 葡萄膜炎并发白内障术中前房注射长效糖皮质激素的疗效[J]. 国际眼科杂志, 2016, 16(12): 2254-2257. DOI: 10.3980/j.issn.1672-5123.2016.12.21
作者姓名:李锐  袁慧敏  刘钊臣  李勇
作者单位:武汉科技大学附属孝感医院 孝感市中心医院眼科, 中国湖北省孝感市,432000
摘    要:目的:研究术中前房注射长效糖皮质激素是否能提高葡萄膜炎并发白内障手术的疗效,以期为临床诊疗提供参考。方法:分析2013-01/2015-01我院收治的接受手术治疗的葡萄膜炎并发白内障患者68例71眼的临床资料。依据治疗方法的不同分为观察组(术中前房注射曲安奈德,35例37眼)及对照组(术中不注射曲安奈德,33例34眼)。对比两组患者的疗效。结果:观察组术后1mo矫正视力>0.5比例显著高于对照组,差异有统计学意义(χ2=4.094,P=0.043)。两组术前及术后眼压比较均无统计学意义(P>0.05)。观察组患者术后前房炎症反应低于对照组,差异具有统计学意义(χ2=15.900,P=0.001);术后1wk,观察组房水内SOD水平显著高于对照组,差异有统计学意义(P<0.05),而MDA及TNF-α水平显著低于对照组水平,差异有统计学意义( P<0.05)。观察组术后1a累积复发率显著低于对照组,差异有统计学意义(14%,5/35 vs 3%,11/33; Log-rank χ2=4.004,P=0.045)。结论:术中前房注射曲安奈德可显著提高葡萄膜炎并发白内障患者手术的疗效。

关 键 词:曲安奈德  葡萄膜炎  白内障  手术  复发
收稿时间:2016-08-29
修稿时间:2016-11-03

Clinical effect of adjuvant therapy with glucocorticoid in surgical treatment of uveitis complicated cataract
Rui Li,Hui-Min Yuan,Zhao-Chen Liu and Yong Li. Clinical effect of adjuvant therapy with glucocorticoid in surgical treatment of uveitis complicated cataract[J]. International Eye Science, 2016, 16(12): 2254-2257. DOI: 10.3980/j.issn.1672-5123.2016.12.21
Authors:Rui Li  Hui-Min Yuan  Zhao-Chen Liu  Yong Li
Affiliation:Department of Ophthalmology,Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan Central Hospital, Xiaogan 432000, Hubei Province, China,Department of Ophthalmology,Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan Central Hospital, Xiaogan 432000, Hubei Province, China,Department of Ophthalmology,Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan Central Hospital, Xiaogan 432000, Hubei Province, China and Department of Ophthalmology,Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan Central Hospital, Xiaogan 432000, Hubei Province, China
Abstract:?AIM: To analyze the clinical effect of adjuvant therapy with glucocorticoid in surgical treatment of uveitis complicated cataract. In order to provide reference for clinical diagnosis and treatment.? METHODS: Clinical data of patients with uveitis complicated cataract who received treatment at our hospital from 2013 to 2015 were analyzed. Patients were divided into two groups by different therapies, Group A:intraoperative injection with triamcinolone, Group B:without treatment of triamcinolone. The near and future curative effect in the two groups patients were compared.?RESULTS: A total of 68 patients were analyzed, Group A had 35 cases ( 37 eyes ) , Group B had 33 cases ( 34 eyes) . Group A patients had a higher rate of patients with a corrected visual acuity more than 0. 5 than that of Group B patients (χ2=4. 094, P=0. 043). There was no significant difference in intraocular pressure between the two groups ( P > 0. 05 ). Anterior chamber inflammation of the observation group patients were lower than the control group, the difference was statistically significant (χ2 =15. 900, P= 0. 001). Seven days after surgery, Group A patients had a higher levels of SOD in aqueous humour and lower levels of MDA and TNF-α in aqueous humour than these of Group B patients ( P> 0. 05 ). Group A patients had a lower 1 year recurrence rate than that of Group B patients (14%,5/35 vs 33%,11/33; Log-rank χ2=4. 004, P=0. 045).
?CONCLUSION:Intraoperative anterior chamber injection with triamcinolone can significantly improve the curative effect in surgical treatment of uveitis complicated cataract.
Keywords:triamcinolone   uveitis   cataract   surgery   recurrence
本文献已被 万方数据 等数据库收录!
点击此处可从《国际眼科杂志》浏览原始摘要信息
点击此处可从《国际眼科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号